Recombinant Human EIF2AK1 (HRI) (N-GST tag)
Catalog No : IGX-RP812
366.40€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
Product name | Recombinant Human EIF2AK1 (HRI) (N-GST tag) | ||
---|---|---|---|
Catalog No | IGX-RP812 | ||
Supplier’s Catalog No | IGX-RP812 | ||
Supplier | ImuGeX | ||
Source antigen | Insect cells | ||
Reactivity | Human | ||
Cross reactivity | |||
Applications | |||
Molecular weight | 120 |
Storage | -70°C | ||
---|---|---|---|
Other names | HCR; HRI; KIAA1369 | ||
Grade | Highly Purified | ||
Purity | 70% - 90% | ||
Form | 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol. | ||
Reactivity life | 6 months | ||
Note | For reserch purpose only | ||
Purity | 70% - 90% | ||
Description | EIF2AK1 (HRI) or eukaryotic translation initiation factor 2-alpha kinase 1 acts at the level of translation initiation to downregulate protein synthesis in response to stress. EIF2AK1 (HRI) is a kinase that can be inactivated by hemin and is activated by heme deficiency and other stimuli and is a major protein kinase that phosphorylates EIF2-alpha . EIF2AK1 (HRI) is downregulated in the majority of ovarian cancers compared with normal ovarian tissues. EIF2AK1 (HRI) functions in iron homeostasis and may play a role in hemolytic and inflammatory anemia . |
© 2020 Imugex All Rights Reserved